Only one in four people experience mild systemic side effects from COVID-19 vaccines

 E-Mail
One in four people experience mild, short lived systemic side effects after receiving either the Pfizer or AstraZeneca vaccine, with headache, fatigue and tenderness the most common symptoms. Most side effects peaked within the first 24 hours following vaccination and usually lasted 1-2 days.
The study published today in the
Lancet Infectious Diseases is the first large scale study to compare the two vaccines and investigate the prevalence of mild side effects of the UK's vaccination programme.
The analysis by researchers from King's College London of data from the ZOE COVID Symptom Study app reassuringly found much fewer side effects in the general population with both the Pfizer and AstraZeneca vaccines than reported in trials.

Related Keywords

United Kingdom ,Israel ,London ,City Of ,Israeli ,Cristina Menni ,King College London ,Pfizer ,Astrazeneca ,Lancet Infectious Diseases ,College London ,Genetic Epidemiology ,Medicine Health ,Critical Care Emergency Medicine ,Epidemiology ,Immunology Allergies Asthma ,Vaccine ,Infectious Emerging Diseases ,ஒன்றுபட்டது கிஂக்டம் ,இஸ்ரேல் ,லண்டன் ,நகரம் ஆஃப் ,இஸ்ரேலி ,கிங் கல்லூரி லண்டன் ,ஃபைசர் ,கல்லூரி லண்டன் ,ஜெநெடிக் தொற்றுநோய் ,மருந்து ஆரோக்கியம் ,